scholarly article | Q13442814 |
P356 | DOI | 10.1016/0002-9343(91)90417-V |
P698 | PubMed publication ID | 1872304 |
P2093 | author name string | P J Guillausseau | |
P2860 | cites work | Diabetic retinopathy and its relation to type of diabetes: review of a retinal clinic population | Q33642064 |
An Approach to the Prevention of Blindness in Diabetes | Q36600846 | ||
The Effect of Temperature on the Fast Hemoglobin Test System | Q39269548 | ||
Clinical and pathogenic significance of pancreatic-islet-cell antibodies in diabetics treated with oral hypoglycaemic agents | Q39433904 | ||
Rapid estimation (2 1/2 hours) of glycosylated haemoglobin for routine purposes | Q39442248 | ||
Haemoglobin A1 and diabetes mellitus | Q39762097 | ||
Relation of diabetic control to development of microvascular complications | Q39774090 | ||
Comparison of HbA1 and fructosamine in diagnosis of glucose-tolerance abnormalities. | Q44602527 | ||
Lack of weight gain with gliclazide treatment for 30 months in type II diabetes | Q47243968 | ||
Islet cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis. | Q51634813 | ||
Glycosylated hemoglobin and fasting plasma glucose in the assessment of outpatient glycemic control in NIDDM. | Q51649307 | ||
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group | Q66972631 | ||
Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents | Q69579956 | ||
Glycosylated hemoglobin and its temporal relationship to plasma glucose in non-insulin dependent (type 2) diabetes mellitus | Q70353027 | ||
Effect of chlorpropamide and gliclazide on plasminogen activator activity in vascular walls in patients with maturity onset diabetes | Q70495821 | ||
P433 | issue | 6A | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | glycated hemoglobin | Q311213 |
P304 | page(s) | 46S-49S | |
P577 | publication date | 1991-06-01 | |
P1433 | published in | American Journal of Medicine | Q2842959 |
P1476 | title | An evaluation of long-term glycemic control in non-insulin-dependent diabetes mellitus: the relevance of glycated hemoglobin. | |
P478 | volume | 90 |
Q37663519 | Effects of gliclazide dose escalation on postprandial hyperglycemia in type 2 diabetes mellitus: A prospective, open-label, case-controlled, dose-escalation study |
Q34082497 | Gliclazide modified release: from once-daily administration to 24-hour blood glucose control. |
Q34082510 | Gliclazide modified release: its place in the therapeutic armamentarium. |
Q40490649 | Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus |
Q51572069 | Management of newly diagnosed non-insulin-dependent diabetes mellitus in the primary care setting: effects of 2 years of gliclazide treatment--the Diadem Study. |
Q40923073 | Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM). |
Search more.